Cannabis Report
Home > Boards > US Listed > Biotechs > Intellipharmaceutics International Inc. (IPCI)

Here are the Focalin competitors

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
fred198484 Member Profile
 
Followed By 2
Posts 437
Boards Moderated 0
Alias Born 07/13/16
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/16/2018 5:08:06 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/13/2018 5:16:17 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/11/2018 4:44:38 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/8/2018 5:27:56 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/22/2018 4:10:49 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/16/2018 8:07:08 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/8/2018 8:06:14 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/27/2018 8:10:54 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/23/2018 5:17:20 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/16/2018 5:16:42 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/16/2018 5:10:45 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 4/3/2018 5:13:01 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/29/2018 6:13:48 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/22/2018 6:07:41 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/21/2018 4:38:55 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 3/21/2018 6:10:39 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 3/20/2018 5:12:58 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/20/2018 4:37:22 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/20/2018 6:08:54 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/20/2018 6:08:53 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/19/2018 3:05:46 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/19/2018 6:10:42 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/16/2018 6:14:56 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/16/2018 6:14:55 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/14/2018 9:10:32 AM
fred198484   Friday, 11/10/17 01:03:29 PM
Re: bluelucky post# 31187
Post # of 35744 
Here are the Focalin competitors


Bloomberg Intelligence: Molecule Detail
Molecule DEXMETHYLPHENIDATE HCL

View TRX Count By Manufacturer By Week


Manufacturer 11/03/2017 10/27/2017 10/20/2017 10/13/2017 10/06/2017 09/29/2017

Total 83.60k 84.98k 83.89k 83.26k 83.23k 84.66k

NOVARTIS 21.76k 22.31k 21.81k 21.69k 21.57k 22.39k
TEVA USA 19.08k 19.41k 19.29k 18.85k 18.98k 18.92k
SANDOZ INC 12.44k 12.81k 12.60k 12.74k 12.73k 13.24k
IMPAX GENERICS 8.43k 8.30k 8.10k 7.71k 7.83k 7.65k
PAR PHARMA 6.21k 6.28k 6.16k 6.10k 5.98k 6.20k
KVK-TECH INC 5.39k 5.38k 5.59k 5.54k 5.64k 5.41k
TRIS PHARMA INC 3.93k 4.02k 3.87k 4.04k 3.91k 4.03k
MYLAN 3.69k 3.70k 3.86k 3.84k 3.85k 4.01k
SUN PHARMA 2.22k 2.32k 2.17k 2.21k 2.23k 2.24k
GAVIS PHARMA 350.00 365.00 327.00 420.00 370.00 411.00
ACTAVIS PHARMA 92.00 100.00 105.00 130.00 148.00 162.00
AHP 1.00 1.00
REPACKER 1.00 1.00 3.00
Source: Symphony Health Solutions 


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist